Browsing Centre for Biochemical Pharmacology by Author "Sugimoto, MA"
Now showing items 1-6 of 6
-
Annexin A1-FPR2/ALX Signaling Axis Regulates Acute Inflammation during Chikungunya Virus Infection
de Araujo, S; Costa, VRDM; Santos, FM; de Sousa, CDF; Moreira, TP; Goncalves, MR; Felix, FB; Queiroz-Junior, CM; Campolina-Silva, GH; Nogueira, ML (2022) -
Formyl peptide receptor type 2 (FPR2) deficiency in myeloid cells amplifies sepsis-induced cardiac dysfunction
Chen, J; Austin-Williams, S; O'Riordan, CE; Claria-Ribas, P; Sugimoto, MA; Norling, LV; Thiemermann, C; Perretti, M (2023) -
Melanocortin therapies to resolve fibroblast-mediated diseases
Khodeneva, N; Sugimoto, MA; Davan-Wetton, CSA; Montero-Melendez, T (2023) -
Resolution of inflammation: what Controls its Onset?
Sugimoto, MA; Sousa, LP; Pinho, V; Perretti, M; Teixeira, MM (2016-04-26) -
RvE1 Attenuates Polymicrobial Sepsis-Induced Cardiac Dysfunction and Enhances Bacterial Clearance
Chen, J; Purvis, GSD; Collotta, D; Al Zoubi, S; Sugimoto, MA; Cacace, A; Martin, L; Colas, RA; Collino, M; Dalli, J (2020-09-02) -
Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease
Costa, VV; Sugimoto, MA; Hubner, J; Bonilha, CS; Queiroz-Junior, CM; Goncalves-Pereira, MH; Chen, J; Gobbetti, T; Libanio Rodrigues, GO; Bambirra, JL (2022)